Literature DB >> 6972178

Prognostic factors in histiocytosis X.

M E Lahey.   

Abstract

It is now clear that the prognosis in children with histiocytosis X has improved considerable over the past few years. To be sure, patients with solitary lesions have an excellent prognosis. Whereas the outlook for patients with significant visceral involvement is not as good as those with bone lesions only, the outlook is by no means hopeless, as was once thought. A number of prognostic factors have been reviewed here. The most significant of these factors at the present time would appear to be age of onset of the disease, extent of involvement, the rapidity of progression of the disease, and, in particular, the presence or absence of dysfunction of such crucial organ systems as liver, lung, and hemopoietic system. Further studies of the significance of histologic features and immunologic findings are clearly needed to further our understanding of this disorder.

Entities:  

Mesh:

Year:  1981        PMID: 6972178

Source DB:  PubMed          Journal:  Am J Pediatr Hematol Oncol        ISSN: 0192-8562


  9 in total

1.  Radionuclide imaging in histiocytosis X.

Authors:  T Schaub; J M Ash; D L Gilday
Journal:  Pediatr Radiol       Date:  1987

2.  Langerhans Cell Histiocytosis (LCH) in Egyptian Children: Does Reactivation Affect the Outcome?

Authors:  Mohamed Sedky Mahmoud Sedky; Hany Abdel Rahman; Emad Moussa; Hala Taha; Tarek Raafat; Omayma Hassanein
Journal:  Indian J Pediatr       Date:  2015-07-03       Impact factor: 1.967

3.  A multicenter study of patients with multisystem Langerhans cell histiocytosis who develop secondary hemophagocytic lymphohistiocytosis.

Authors:  Deepak Chellapandian; Melissa R Hines; Rui Zhang; Michael Jeng; Cor van den Bos; Vicente Santa-María López; Kai Lehmberg; Elena Sieni; Yini Wang; Taizo Nakano; James A Williams; Nicholas J Fustino; Itziar Astigarraga; Ira J Dunkel; Oussama Abla; Astrid G S van Halteren; Deqing Pei; Cheng Cheng; Sheila Weitzman; Lillian Sung; Kim E Nichols
Journal:  Cancer       Date:  2018-12-06       Impact factor: 6.860

4.  Adult onset of multisystem Langerhans cell histiocytosis with skin and lymph node involvement.

Authors:  Izabela Błażewicz; Wojciech Biernat; Anna Kowalczyk; Wioletta Barańska-Rybak; Roman Nowicki; Marta Stawczyk-Macieja; Małgorzata Sokołowska-Wojdyło
Journal:  Postepy Dermatol Alergol       Date:  2015-06-15       Impact factor: 1.837

Review 5.  Insights into the pathogenesis of Langerhans cell histiocytosis: the development of targeted therapies.

Authors:  Caroline Hutter; Milen Minkov
Journal:  Immunotargets Ther       Date:  2016-10-12

6.  Bone marrow infiltration in Langerhan's cell histiocytosis - An unusual but important determinant for staging and treatment.

Authors:  Mahendra Kumar; Man Updesh Singh Sachdeva; Shano Naseem; Jasmina Ahluwalia; Reena Das; Neelam Varma; R K Marwaha
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2015-10-01

7.  The combination of methotrexate and cytosine arabinoside in newly diagnosed adult Langerhans cell histiocytosis: a prospective phase II interventional clinical trial.

Authors:  Xiao Han; Mingqi Ouyang; Minghui Duan; Wei Zhang; Tienan Zhu; Jian Li; Shujie Wang; Daobin Zhou
Journal:  BMC Cancer       Date:  2020-05-18       Impact factor: 4.430

8.  Isolated Langerhans cell histiocytosis of the spleen: A case report.

Authors:  Le Hong; Gen Sun; Long Peng; Yi Tu; Yong Li; Weidong Xiao
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

9.  Clinical presentation and prognostic analysis of adult patients with Langerhans cell histiocytosis with pulmonary involvement.

Authors:  Hui-Lei Miao; Ai-Lin Zhao; Ming-Hui Duan; Dao-Bin Zhou; Xin-Xin Cao; Jian Li
Journal:  BMC Cancer       Date:  2020-09-23       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.